Table 3

Risk of bias in included studies assessed by the ROBINS-I tool

Risk-of-bias domains
Study, yearConfoundingSelection of participantsClassification of interventionsDeviations from intended interventionMissing dataMeasurement of outcomesOverall risk of biasSelection of reported result
Vaccination before SARS-CoV-2 infection
Al-Aly 202219LowLowLowLowLowModerateLowModerate
Antonelli 202220ModerateLowLowLowSeriousSeriousLowSerious
Ayoubkhani 202221CriticalLowLowLowModerateLowLowCritical
Azzolini 202222ModerateLowModerateLowNICriticalLowCritical
Ioannou 202223ModerateLowLowLowNILowModerateModerate
Mohr 202224SeriousSeriousLowLowSeriousModerateModerateSerious
Pell 202225SeriousLowSeriousLowSeriousModerateModerateSerious
Tannous 202226SeriousLowLowLowLowSeriousNISerious
Taquet 202127ModerateLowLowLowNILowLowModerate
van der Maaden 202228SeriousLowModerateLowLowLowLowSerious
Zisis 202229SeriousCriticalSeriousLowNISeriousNICritical
Vaccination after SARS-CoV-2 infection or after diagnosis of long covid
Ayoubkhani 202230LowLowLowLowModerateLowLowModerate
Simon 202131SeriousLowLowLowModerateLowLowSerious
Tran 202132ModerateLowLowLowLowLowLowModerate
Wisnivesky 202233SeriousSeriousSeriousLowLowLowLowSerious
Wynberg 202234SeriousModerateSeriousLowLowSeriousLowSerious
  • NI=no information.